Carla Walker Act
- Sponsor
- Rep. Hunt, Wesley [R-TX-38]
- Committees
- Judiciary Committee (primary)
- Last action
- May 23, 2025
Bottom line
The Carla Walker Act authorizes $10 million annually in federal grants to enhance state and local law enforcement's capacity to use advanced forensic genetic genealogy for solving cold cases and identifying human remains.
What it actually does
This bill establishes two new competitive grant programs under the Omnibus Crime Control and Safe Streets Act of 1968. One program provides grants to eligible entities (states, law enforcement, prosecutors, medical examiners, and coroners) to conduct DNA analyses using whole genome sequencing technology when traditional methods like CODIS fail, or to identify human remains. The second program offers grants to publicly funded forensic laboratories, medical examiners, and coroners to purchase equipment and supplies necessary for deploying forensic genetic genealogical DNA analysis in-house.
Proponents argue
Supporters argue that this bill provides critical funding for advanced forensic technologies, enabling law enforcement to solve challenging cold cases, identify victims, and bring perpetrators to justice, especially when traditional DNA databases yield no leads. They emphasize the importance of leveraging cutting-edge science to enhance public safety, provide closure to families, and ensure that justice is served.
Opponents contend
Critics might raise concerns about the privacy implications associated with the use of genealogical databases for law enforcement purposes, particularly for individuals whose genetic information is used without their explicit consent for criminal investigations. They may also question the potential for misidentification or the ethical considerations of searching private genetic information, advocating for stronger safeguards.
The bill is relatively short and clearly structured, making it accessible for an informed reader to understand its provisions within a reasonable timeframe.
Section 1
Short Title: Carla Walker Act
This section formally names the bill the 'Carla Walker Act.' This practice is often used to honor individuals or to provide a memorable and easily referenced name for the legislation, typically reflecting a specific case or cause that inspired the bill.
Supporters argue
Supporters argue that naming the bill after a victim of crime helps to humanize the legislation, underscores the importance of its goals in solving similar cases, and provides a powerful symbol of the pursuit of justice and closure for families.
Critics contend
No specific opposition is typically raised against short titles, as they are largely symbolic and do not alter the substantive provisions of the legislation.
Tradeoffs
None significant, as short titles are primarily for identification and symbolic purposes.
Title I of the Omnibus Crime Control and Safe Streets Act of 1968, Part PP, Section 3062
DNA Analysis Grants
This section authorizes the Attorney General to award competitive grants to states, tribal and local law enforcement agencies, prosecutor's offices with forensic lab capabilities, medical examiners, and coroners. These grants are specifically for conducting DNA analyses using whole genome sequencing technology (assessing at least 100,000 genetic markers) that is compatible with multiple genealogical databases. Funds can be used for samples that failed to produce leads in the Combined DNA Index System (CODIS) or for unidentified human remains. The grants also allow for outsourcing these activities to accredited or qualifying nongovernmental forensic laboratories.
Title I of the Omnibus Crime Control and Safe Streets Act of 1968, Part PP, Section 3063
Grants to Purchase Forensic Equipment
This section authorizes the Attorney General to award grants to publicly funded and accredited forensic laboratories, medical examiners' offices, and coroners' offices. The primary purpose of these grants is to enable these entities to purchase the necessary forensic equipment, including supplies, reagents, consumables, and to cover validation expenses, for deploying forensic genetic genealogical DNA analysis and searching capabilities in-house.
Activities carried out using grant funds must be consistent with the Department of Justice's 'Interim Policy on Forensic Genealogical DNA Analysis and Searching' (dated November 1, 2019) or any successor policy. This includes specific requirements for communication between CODIS laboratories and vendor laboratories. Grant recipients are also required to maintain records and allow audit access to ensure compliance with this policy, particularly Section VIII, 'Sample and Data Control and Disposition.'
Section 3062(d)(2) and Section 3064(b)
Why it matters:This is standard legislative practice to incorporate existing administrative policies by reference, rather than re-stating them in full. It ensures consistency with current federal guidelines and allows for administrative flexibility as policies evolve.
Case for: Supporters argue that linking grant activities to an established DOJ policy provides necessary safeguards, ethical guidelines, and operational standards for sensitive genetic genealogy work, ensuring responsible use of the technology and protecting privacy.
Case against: Critics might argue that relying on an 'interim' policy, or any policy that can be unilaterally changed by the DOJ, provides less legislative certainty and oversight than codifying specific protections within the bill itself, potentially leaving privacy safeguards vulnerable to administrative shifts.
Estimated impact: Ensures that all federally funded forensic genetic genealogy activities operate under a consistent set of ethical and procedural guidelines, impacting data handling, privacy, and investigative practices nationwide.
Nongovernmental forensic laboratories that receive outsourced work under the DNA analysis grant program must attest to the Attorney General, in a legally binding and enforceable manner, that they will prepare and apply for accreditation not later than 2 years after the date on which they first receive a request for analysis from an eligible entity receiving a grant.
Section 3062(d)(1)(C)(iii)
Why it matters:This is likely a practical compromise to allow newer or smaller specialized labs to participate in the program while still ensuring a pathway to quality control and standardization, acknowledging that some cutting-edge expertise might reside in labs not yet fully accredited.
Case for: Proponents argue this provision allows for the immediate utilization of specialized private labs that may not yet be accredited but possess critical expertise, while simultaneously pushing them towards formal accreditation, ensuring quality control in the long run.
Case against: Critics might contend that allowing unaccredited labs to perform sensitive forensic analysis, even with a promise of future accreditation, introduces a risk of errors or inconsistencies that could compromise investigations or legal proceedings, potentially undermining the integrity of evidence.
Estimated impact: Broadens the pool of eligible service providers for advanced DNA analysis while establishing a timeline for quality assurance, potentially increasing the speed and availability of these services, but with a temporary allowance for unaccredited entities.